Article - 28/02/2011 The regulation of the intestinal immune system If the interplay of factors that regulate the intestinal immune system tips out of balance, this could result in allergic reactions or serious inflammatory intestinal diseases. Professor Dr. med. Stefan Meuer, Managing Director of the Institute for Immunology at the University Hospital in Heidelberg, is focusing on the molecular mechanisms of mucosal immune regulation. https://www.gesundheitsindustrie-bw.de/en/article/news/the-regulation-of-the-intestinal-immune-system
Article - 14/02/2011 A molecule that enables local virus defence Dr. Markus Mordstein has spent the last four years as a doctoral student at the University of Freiburg investigating the previously relatively unknown interferon lambda. He has been able to show that this molecule has similar protective functions to type I interferons and he has also found that it is far more selective in terms of the site where it exerts its effect.https://www.gesundheitsindustrie-bw.de/en/article/news/a-molecule-that-enables-local-virus-defence
Press release - 31/01/2011 Researchers from Stuttgart decipher the function of antibiotics that are naturally produced by the human body Researchers at the Robert Bosch Hospital RBK and the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology IKP in Stuttgart have now deciphered a new mechanism of action of the human immune system that protects against intestinal bacteria and pathogenic yeasts. The internationally renowned scientific journal Nature presents their findings.https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-from-stuttgart-decipher-the-function-of-antibiotics-that-are-naturally-produced-by-the-h
Article - 12/01/2011 How milk, cheese, yoghurt and curd cheese can be kept free from “genetic engineering” Bacteriophages introduce their DNA into bacteria where they quickly reproduce and eventually destroy the host organism. Phages are omnipresent in nature and some can be dangerous for humans. They also represent a huge contamination risk in the production of fermented food. Canadian researchers Lvesque et al. 2005 estimate that phages cause around 10 per cent of all production losses in the diary industry where they infest bacteria such as…https://www.gesundheitsindustrie-bw.de/en/article/news/how-milk-cheese-yoghurt-and-curd-cheese-can-be-kept-free-from-genetic-engineering
Article - 20/12/2010 Invisible danger with long-term consequences According to official figures mycotoxins which are toxic secondary metabolites produced by moulds are found in around of 20 per cent of the European crop harvest. Even the smallest concentrations of mycotoxins can have devastating toxic effects causing cancer or posing a risk to fertility and development. Alexandra Heussner from the University of Konstanz is investigating ochratoxins whose chronic effect represents a huge danger to human health.https://www.gesundheitsindustrie-bw.de/en/article/news/invisible-danger-with-long-term-consequences
Article - 08/11/2010 Molecular biology assisted by information theory What do the Internet and mobile communication have in common with the division of yeast cells and viruses? Quite a lot, says Martin Bossert, professor at the Institute of Telecommunication Technology and Applied Information Theory in Ulm. The 55-year-old engineer coordinates an interdisciplinary priority programme of the German Research Foundation (DFG, SPP 1395 Information and Communication Theory in Molecular Biology) that applies information…https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-biology-assisted-by-information-theory
Article - 08/11/2010 The masters of cellular circuits What can nowadays be constructed with molecular building sets? Prof. Dr. Wilfried Weber from the Centre for Biological Signalling Studies BIOSS in Freiburg is the first scientist at the University of Freiburg to receive the prestigious Starting Grant from the European Research Council ERC with a purse of 1.5 million euros. Webers team recombines cellular components and works on a broad range of different issues.https://www.gesundheitsindustrie-bw.de/en/article/news/the-masters-of-cellular-circuits
Press release - 26/10/2010 Peripheral Induction of Alzheimer-Like Brain Pathology in Mice Pathological protein deposits linked to Alzheimers disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration outside the brain. This is shown in a new study done by researchers at the Hertie Institute of Clinical Brain Research in Tübingen. https://www.gesundheitsindustrie-bw.de/en/article/press-release/peripheral-induction-of-alzheimer-like-brain-pathology-in-mice
Dossier - 18/10/2010 New machines for the life sciences Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…https://www.gesundheitsindustrie-bw.de/en/article/dossier/new-machines-for-the-life-sciences
Article - 17/10/2010 A high-tech strategy to become a reference laboratory The Konstanz-based Labor Dr. Brunner is the first medical laboratory in Germany to use a worldwide revolutionary instrument for liquid sample processing in bacteriological laboratories. The Walk-Away Specimen Processor (WASP) is a faster and more reliable processor that automatically identifies resistant pathogens such as MRSA or ESBL-type bacteria that have become part of the growing number of antibiotic-resistant pathogens that cause…https://www.gesundheitsindustrie-bw.de/en/article/news/a-high-tech-strategy-to-become-a-reference-laboratory
Article - 18/09/2010 Empa Testmaterials: assessing the effectiveness of washing processes Empa Testmaterials AG focuses on the research and development of test systems and materials that enable biofilm to be successfully removed from washing machines as well as controlling the level of hygiene of individual wash cycles. As a competence centre in washing and cleaning the company specialises in the assessment of washing and cleaning processes in terms of effectiveness energy efficiency damage and hygiene.https://www.gesundheitsindustrie-bw.de/en/article/news/empa-testmaterials-assessing-the-effectiveness-of-washing-processes
Press release - 09/09/2010 C&O Pharmaceutical Technology (Holdings) Ltd., Nanjing Headquartered in Hong Kong and listed on the Singapore Exchange since October 2005 CO Pharmaceutical Technology Holdings Limited CO is an integrated pharmaceutical group in the Peoples Republic of China. The business model spans the entire value chain in the pharmaceutical industry which includes Reasearch and Development RD manufacturing marketing and distribution of CO branded respectively third party pharmaceutical products.https://www.gesundheitsindustrie-bw.de/en/article/press-release/c-o-pharmaceutical-technology-holdings-ltd-nanjing
Dossier - 30/08/2010 Disease prevention through better diagnostics “Classical treatment approaches are not the only way to ensure good health, rehabilitation and care. In fact, it is envisaged that more effective prevention will contribute to halting the development of diseases and maintaining good health. Prevention is designed to prevent health risks and diseases, make them less likely and delay their onset.” (Declaration of the German government; Official Records of Parliament 17/845, 26th February 2010) https://www.gesundheitsindustrie-bw.de/en/article/dossier/disease-prevention-through-better-diagnostics
Article - 30/08/2010 Diagnostics for the early detection of cervical cancer The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.https://www.gesundheitsindustrie-bw.de/en/article/news/diagnostics-for-the-early-detection-of-cervical-cancer
Article - 23/08/2010 Antibiotics for the prevention of malaria Researchers from Heidelberg and Berlin have shown that if malaria-infected mice are administered an antibiotic, no parasites appear in the blood and the mice are protected from this life-threatening disease. The scientists believe that antibiotics also have the potential to strengthen the human immune system as well as making it possible to provide a natural needle-free vaccination against malaria.https://www.gesundheitsindustrie-bw.de/en/article/news/antibiotics-for-the-prevention-of-malaria
Article - 23/08/2010 Signals that trigger symbiotic relationships Some fungi kill plants by wearing them down. Other fungi however are on friendly terms with plants. The research group led by Prof. Dr. Natalia Requena from the Karlsruhe Institute of Technology KIT investigates the molecular mechanisms that enable fungi and plants to initiate contact with each other. How do plants differentiate good from bad fungi? How do they manage to set up a functional and effective symbiotic relationship?https://www.gesundheitsindustrie-bw.de/en/article/news/signals-that-trigger-symbiotic-relationships
Article - 01/08/2010 Manfred Kist – 25 years of fascination for a stomach bacterium Helicobacter pylori is a genus of bacteria that inhabits the human stomach. The bacteria can cause duodenal and gastric ulcers and are also linked to the development of gastric cancer. Prof. Dr. Manfred Kist from the Freiburg University Medical Centre has spent around 25 years of his scientific career on investigating H. pylori a bent rod-shaped bacterium.https://www.gesundheitsindustrie-bw.de/en/article/news/manfred-kist-25-years-of-fascination-for-a-stomach-bacterium
Article - 31/07/2010 Christian Riedel – an outstanding bifidobacteria researcher The 37-year-old microbiologist Christian Riedel was recently awarded the Science Prize of the city of Ulm for his basic research on bifidobacteria. Riedel who is the head of a group of 12 junior researchers at the University of Ulm has shown that bifidobacteria exert an inhibitory effect on chronic bowel inflammation. The researcher hopes to have identified the underlying molecular mechanisms within the next 12 months.https://www.gesundheitsindustrie-bw.de/en/article/news/christian-riedel-an-outstanding-bifidobacteria-researcher
Article - 03/07/2010 Erbasens: Using the power of nature Before setting up her own company biologist Dr. Elke Schulz amassed a wealth of knowledge in the pharmaceutical industry. Now she harnesses the power of plants to develop and sell dietary supplements and natural cosmetics. Her company Erbasens specialises in combining high-quality oils and plant essences to create products such as Paramirum that safeguards the effectiveness of the immune system and promotes the bodys defence systems.https://www.gesundheitsindustrie-bw.de/en/article/news/erbasens-using-the-power-of-nature
Press release - 25/06/2010 Von-Langenbeck Prize awarded for the first time to regenerative medicine methods In 2010 the Von-Langenbeck Prize was awarded to Dr. Thorsten Walles from the Schillerhöhe Hospital in Stuttgart. In cooperation with his partners Walles has developed an innovative method for regenerative medicine applications which involves the generation of tissue from the patients own cells to replace defective air pipes and oesophagus. The prize was awarded for the first time ever to a medical doctor in recognition of the development and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/von-langenbeck-prize-awarded-for-the-first-time-to-regenerative-medicine-methods
Article - 15/04/2010 Bone-hard basic research for an ageing society Osteoporotic bones not only break very easily, they also heal badly when a fracture occurs. A fractured femur neck might mean that elderly patients have to remain bedridden for a long period and maybe even need nursing care. Fractures that heal badly, in combination with other diseases, frequently lead to a fatal outcome. A panregional team of researchers, including researchers from Ulm, has been working together since 2007 on basic research into…https://www.gesundheitsindustrie-bw.de/en/article/news/bone-hard-basic-research-for-an-ageing-society
Article - 26/03/2010 How do killer cells manage to survive? It is not easy for the body to protect itself once a virus has broken through the body’s lines of defence and caused a chronic infection. This task is made even more difficult when the intruders are viral hepatitis pathogens that attack the liver, the place where immunological tolerance is induced. Jörg Reimann (physician) and Reinhold Schirmbeck (biologist) are working on the development of T-cell-mediated therapeutic vaccination strategies to…https://www.gesundheitsindustrie-bw.de/en/article/news/how-do-killer-cells-manage-to-survive
Article - 15/03/2010 Innovative navigation system enables gene shuttles to reach their destination If everything goes to plan the Department of Gene Therapy at the University of Ulm will soon lose a work group to industry. Florian Kreppels team plans to turn a particular technology into hard cash using a method that can do something other gene shuttles are unable to do namely transport their freight to a specific destination.https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-navigation-system-enables-gene-shuttles-to-reach-their-destination
Article - 15/03/2010 Cystic fibrosis therapy is making good progress Thirty years ago cystic fibrosis CF formerly also known as mucoviscidosis was considered to be a disease that only affected children. Hardly any children with this hereditary metabolic disease ever reached early adulthood. Since then both the therapy and the life expectancy of CF patients have improved considerably. Dr. Gerd Döring from Tübingen is investigating the occurrence of respiratory tract defects that are common in CF patients.https://www.gesundheitsindustrie-bw.de/en/article/news/cystic-fibrosis-therapy-is-making-good-progress
Article - 25/02/2010 Focus on new antimycotics targets Yeast infections are becoming a growing threat in intensive care medicine and only a small number of effective drugs – so-called antimycotics – are available. The scientist Dr. Steffen Rupp from Stuttgart is investigating the individual steps of the infection process in order to find key mechanisms in the fungus that can be targeted. https://www.gesundheitsindustrie-bw.de/en/article/news/focus-on-new-antimycotics-targets